S. 4189 — 119th Congress
Federal bill
INSULIN Act of 2026
- Title
- INSULIN Act of 2026
- Official title
- A bill to reduce the price of insulin and provide for patient protections with respect to the cost of insulin.
- Type
- Senate bill
- Congress
- 119th Congress
- Chamber of origin
- Senate
- Introduced
- 2026-03-25
- Latest action
- Placed on Senate Legislative Calendar under General Orders. Calendar No. 552.
- Latest action date
- 2026-08-07
Organizations that named this bill in federal lobbying filings
- NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERS Federal lobbying client (LDA)
- AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) Federal lobbying client (LDA)
- BLUE CROSS AND BLUE SHIELD ASSOCIATION Federal lobbying client (LDA)
- BLUE CROSS AND BLUE SHIELD OF FLORIDA INC Federal lobbying client (LDA)
- HIGHMARK INC Federal lobbying client (LDA)
Federal lobbying filings naming this bill
U.S. Senate Lobbying Disclosure Act database. A filing names bills, issues and agencies — never the member lobbied — so these rows point only at the client organization, and none of them says any member of Congress was lobbied about this bill. The count is filings in this site's LDA slice, not the
- NATIONAL ASSOCIATION OF PEDIATRIC NURSE PRACTITIONERS cited in the filing's issue text 2 filings
- AMERICA'S HEALTH INSURANCE PLANS INC (AHIP) cited in the filing's issue text 1 filing
- BLUE CROSS AND BLUE SHIELD ASSOCIATION cited in the filing's issue text 1 filing
- BLUE CROSS AND BLUE SHIELD OF FLORIDA INC cited in the filing's issue text 1 filing
- HIGHMARK INC cited in the filing's issue text 1 filing